The store will not work correctly when cookies are disabled.
3-[N-(3-Phenylpropyl)amino]-4-methylbenzhydroxamic acid
ID: ALA4099064
PubChem CID: 137661848
Max Phase: Preclinical
Molecular Formula: C17H20N2O2
Molecular Weight: 284.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(=O)NO)cc1NCCCc1ccccc1
Standard InChI: InChI=1S/C17H20N2O2/c1-13-9-10-15(17(20)19-21)12-16(13)18-11-5-8-14-6-3-2-4-7-14/h2-4,6-7,9-10,12,18,21H,5,8,11H2,1H3,(H,19,20)
Standard InChI Key: KVQDENKEOQLMNA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
17.3742 -13.3515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3731 -14.1711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0811 -14.5800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7908 -14.1706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7879 -13.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0793 -12.9427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6650 -14.5791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4991 -14.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5004 -15.3953 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2062 -14.1684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9145 -14.5759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6664 -12.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9577 -14.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2496 -14.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5422 -14.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8412 -14.5765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1422 -14.1696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4416 -14.5766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4437 -15.3884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1521 -15.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8498 -15.3822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
4 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
1 12 1 0
7 13 1 0
13 14 1 0
14 15 1 0
16 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.36 | Molecular Weight (Monoisotopic): 284.1525 | AlogP: 3.16 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.20 | CX Basic pKa: 4.21 | CX LogP: 3.26 | CX LogD: 3.26 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.43 | Np Likeness Score: -1.18 |
References
1. Heimburg T, Kolbinger FR, Zeyen P, Ghazy E, Herp D, Schmidtkunz K, Melesina J, Shaik TB, Erdmann F, Schmidt M, Romier C, Robaa D, Witt O, Oehme I, Jung M, Sippl W.. (2017) Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity., 60 (24): [PMID:29190092] [10.1021/acs.jmedchem.7b01447] |